Physician profile
Timothy James Linker
NPI 1417955428
$5,592.92
in general payments reported to CMS, 2019-2025
46 companies · $1,208 in 2025
The $1,208 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $611 · 2021: $745 · 2022: $795 · 2023: $746 · 2024: $1,102 · 2025: $1,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,055 · Education: $1.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,054.66 |
| Education | $1.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $930.14 | 2019-2025 | |
| Novo Nordisk INC | $644.51 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $532.82 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $471.69 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $338.16 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $271.56 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.88 | 2019-2025 | Jardiance |
| Amgen INC. | $183.51 | 2019-2025 | Otezla, Repatha |
| Corium, LLC | $149.10 | 2022-2024 | Azstarys |
| Amarin Pharma, INC. | $145.79 | 2019-2021 | |
| Exact Sciences Corporation | $140.17 | 2023-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $133.90 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $115.50 | 2021-2025 | Zoryve |
| Astellas Pharma US INC | $106.97 | 2024-2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $106.06 | 2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Linker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.